Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: A cohort study

Rheumatology (United Kingdom)

Volumn 52, Issue 3, 2013, Pages 547-553

  Krieckaert, Charlotte L M ^a   Nurmohamed, Michael T ^a   Wolbink, Gertjan ^a   Lems, Willem F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adalimumab; Osteoporosis; Rheumatoid arthritis; TNF inhibitor

Indexed keywords

ADALIMUMAB;

ADULT; ARTICLE; BONE DENSITY; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL X RAY RADIOGRAMMETRY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; METACARPAL BONE; OSTEOLYSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; X RAY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; COHORT STUDIES; FEMALE; HAND; HIP; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES, CYCLIC; TIME FACTORS;

EID: 84874095703     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes320     Document Type: Article

References (28)

1. Nolla JM, Roig-Vilaseca D, Gomez-Vaquero C et al. Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital. J Rheumatol 2006;33:1472-5.
2. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43:522-30.
3. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;15:337-42.
4. Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 2010;233: 301-12.
5. Cortet B, Flipo RM, Blanckaert F et al. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy. Rev Rhum Engl Ed 1997;64:451-8.
6. Cortet B, Guyot MH, Solau E et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol 2000;18:683-90.
7. Wijbrandts CA, Klaasen R, Dijkgraaf MG et al. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis 2009;68:373-6.
8. Marotte H, Pallot-Prades B, Grange L et al. A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab. Arthritis Res Ther 2007;9:R61.
9. Chopin F, Garnero P, le Henanff A et al. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67:353-7.
10. Vis M, Havaardsholm EA, Haugeberg G et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1495-9.
11. Eekman DA, Vis M, Bultink IE et al. Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70:389-90.
12. Hoff M, Haugeberg G, Odegård S et al. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis 2009;68:324-9.
13. Hoff M, Haugeberg G, Kvien TK. Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss. Arthritis Res Ther 2007;9:R81.
14. Haugeberg G, Ørstavik RE, Uhlig T et al. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8.
15. Shibuya K, Hagino H, Morio Y, Teshima R. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 2002;21:150-8.
16. Pfeil A, Lippold J, Eidner T et al. Effects of leflunomide and methotrexate in rheumatoid arthritis detected by digital X-ray radiogrammetry and computer-aided joint space analysis. Rheumatol Int 2009;29:287-95.
17. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
18. Dolan AL, Moniz C, Abraha H, Pitt P. Does active treatment of rheumatoid arthritis limit disease-associated bone loss? Rheumatology 2002;41:1047-51.
19. Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Krzysztof L Łacki J. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients? Clin Rheumatol 2008;27:565-72.
20. Haugeberg G, Strand A, Kvien TK, Kirwan JR. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebocontrolled trial. Arch Intern Med 2005;165:1293-7.
21. Hoff M, Haugeberg G, Odegård S et al. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis 2009;68:324-9.
22. Kapetanovic MC, Lindqvist E, Algulin J et al. Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis. Arthritis Res Ther 2011; 13:R31.
23. Hoff M, Kvien TK, Kä lvesten J et al. Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: subanalysis of the PREMIER study. BMC Musculoskelet Disord 2011;27:54.
24. Cummings SR, San Martin J, McClung MR et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009;361: 756-65.
25. Jarrett SJ, Conaghan PG, Sloan VS et al. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 2006;54:1410-4.
26. Engvall IL, Tengstrand B, Brismar K, Hafström I. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over months. Arthritis Res Ther 2010;12:R197.
27. Briot K, Gossec L, Kolta S, Dougados M, Roux C. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008;35:855-61.
28. Baker JF, George M, Baker DG et al. Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Rheumatology 2011;50:2100-7.